21 May 2013
Keywords: 20m, gsk, milestone, pozen, north, carolina, usa-based
Article | 05 May 2008
North Carolina, USA-based drug developer Pozen has received a total of $20.0 million in milestone payments from UK drug major GlaxoSmithKline
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
5 May 2008
20 May 2013
© 2013 thepharmaletter.com